Clinical Trial Update: Mesalazine With Hydrocortisone Sodium Succinate Enema for 4-Week Treatment in Patients With Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a mesalazine with hydrocortisone sodium succinate enema for four weeks in ulcerative colitis. The snippet does not prov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mesalazine with Hydrocortisone Sodium Succinate Enema

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Ulcerative Colitis, Unspecified | Phase 4 | Status: UNKNOWN